Why the study?
Does antiviral treatment reduce hospitalizations and other severe outcomes in patients with influenza?
Does antiviral treatment reduce hospitalizations and other severe outcomes in patients with influenza?
Answers are grounded in this paper and cite their sources.
Highlights the need for well-conducted real-world observational studies to complement RCTs in defining the benefits of antiviral treatment for influenza.
More evidence is needed to define the benefits and role of antiviral treatment to reduce risk of severe influenza outcomes based on clinical risk factors and timing. Well-conducted real-world observational studies can complement evidence from randomized controlled trials to address critical gaps.
No takes yet. Share an insight, caveat, or question.
Tenforde et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: